Effects of a Health Workforce Capacity Building and Quality Improvement Intervention in Kinshasa

Sponsor
Jhpiego (Other)
Overall Status
Completed
CT.gov ID
NCT03363308
Collaborator
Bill and Melinda Gates Foundation (Other)
250
1
2
31.4
8

Study Details

Study Description

Brief Summary

The aim of the study is to evaluate a health workforce capacity building and quality improvement intervention focused on integrated day-of-birth and post-pregnancy care at 16 hospitals in Kinshasa, Democratic Republic of Congo. The intervention package consists of a low-dose, high-frequency (LDHF) training of health workers, support for quality improvement teams, and provision of critical equipment, supplies and drugs within a quality improvement (QI) framework.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: training for health care workers supplmented by QI teams
N/A

Detailed Description

The health workforce capacity building and quality improvement intervention will be implemented in two phases: eight facilities will receive the intervention in phase 1 and the remaining eight facilities will receive the intervention in phase 2.

Objective 1: For objective 2 on facility-based health outcomes, the study design is a cluster-randomized evaluation in phase 1. The intervention's effects will be assessed by comparing an intervention group and a control group of facilities. These will be selected from 16 Kinshasa health facilities. Intervention and control facilities' monthly reported health outcomes will be compared in a 12-month baseline period and 12-month period during and after the intervention implementation (Phase 1) in a difference-in-difference analysis. In Phase 2, all facilities will have their monthly service statistics and health outcomes reviewed for trends in improvement.

Overall, in Phase 1, eight intervention sites will be matched to eight sites serving as controls. In Phase 2, the eight Phase 1 control sites will then receive the same package as the intervention sites in Phase 1. Sites will be stratified by case load, low and high (over 90 births per month), and funding (public or private funding). Within each stratum, prior to start of the intervention, there will be random selection to intervention and control groups to allow for baseline comparability between groups.

Study Design

Study Type:
Interventional
Actual Enrollment :
250 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This is a cluster-randomized trial in phase I and interrupted time series in phase IIThis is a cluster-randomized trial in phase I and interrupted time series in phase II
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effects of a Health Workforce Capacity Building and Quality Improvement Intervention on Intrapartum Stillbirth, Early Newborn Mortality and Post-pregnancy Family Planning in Kinshasa: a Cluster Randomized Evaluation
Actual Study Start Date :
Nov 16, 2017
Actual Primary Completion Date :
Jun 30, 2020
Actual Study Completion Date :
Jun 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Phase 1

training for health care workers supplemented by QI teams

Behavioral: training for health care workers supplmented by QI teams
Jhpiego will deliver maternal and newborn health and family planning (MNH+FP) training using evidence-based low-dose, high-frequency (LDHF) learning approaches and support hospital staff-led quality improvement efforts to increase the coverage of facility-based high-impact interventions, including care of the mother and newborn on the day of birth and through the first week postpartum and post abortion services.
Other Names:
  • Practice coordinator training after training session
  • Practice sessions using anatomic models
  • SMS reminder messages and quizzes
  • Routine calls between mentors and providers
  • Health information officer training
  • Data collection and use training
  • Supply of simulators, equipment, kits and other
  • Develop quality improvement teams and review of action plans
  • Routine calls between project staff and mentors
  • No Intervention: Phase 2

    Outcome Measures

    Primary Outcome Measures

    1. Mean number or percent of items correctly answered [1 day]

      Each observed structured clinical exam (OSCE) or knowledge tests has between 13 and 38 items. A participant needs to achieve 85% correct score to pass at post-training to assess provider competencies. The main indicator for analysis will be the mean number of items (or percent of items) correctly answered. This mean percent of items correctly answered will be done pre-training, post-training and after 6 months. This will be done in the 8 intervention group facilities only in Phase I and again in the 8 new facilities in Phase II.

    2. Intrapartum perinatal death ratio [1 day]

      Defined as death of a fetus during labor who had heart tones documented on arrival in the maternity and neonatal deaths prior to 24 hours, divided by total births.

    3. Percent of women after childbirth who adopt a family planning method immediately post-pregnancy or intend to adopt a method by six weeks post-pregnancy. [3 days]

      Percent of women after childbirth who adopt a family planning method over all women who give birth in a facility

    Secondary Outcome Measures

    1. maternal mortality [3 days]

      number of maternal deaths over number of live births

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Health providers:

    • Currently on the roster of maternity ward providers working at one of the 16 selected facilities at the time of the training module.

    • Willing to attend a Jhpiego clinical training workshop and offer consent as study participant.

    • Age 18 or older.

    Exclusion Criteria:
    • there are no exclusion criteria

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Jhpiego DRC Kinshasa Congo, The Democratic Republic of the

    Sponsors and Collaborators

    • Jhpiego
    • Bill and Melinda Gates Foundation

    Investigators

    • Principal Investigator: Virgile Kikaya, Jhpiego DRC

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jhpiego
    ClinicalTrials.gov Identifier:
    NCT03363308
    Other Study ID Numbers:
    • OPP1156220
    First Posted:
    Dec 6, 2017
    Last Update Posted:
    Jul 24, 2020
    Last Verified:
    Jul 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 24, 2020